@Rogerfak, 35ish. I think it can go to $40 though. They are doing a presentation where they compare it to Botox soon, which will bring in more buyers. I'm guessing the results will be good seeing as the CEO left Allergan (the maker of Botox) for this opportunity. Directors also chased stock in the mid 30's. They won't do an offering until the presentation. Would be ridiculous for them to do so. Traders will be all over this too. That range and float is $$, as we just saw today. Bounced off that prior support and exploded 10% intraday #BuyTheDIp